SCHEMBL19514751

SCHEMBL19514751

COc1ccc(COC(=O)SOC(=O)O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.49
ALDH1A1 P00352 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MMP9 P14780 2/20 0.48
MMP1 P03956 1/20 0.48
MMP2 P08253 1/20 0.47
MMP12 P39900 1/20 0.47
FFAR1 O14842 1/20 0.47
HTT P42858 2/20 0.46
LDHA P00338 1/20 0.46
ATM Q13315 1/20 0.46
FABP7 O15540 1/20 0.46
FABP5 Q01469 1/20 0.46
PLA2G4B P0C869 1/20 0.43
IDO1 P14902 1/20 0.43
AGXT P21549 1/20 0.43
KDM4E B2RXH2 1/20 0.43
SAE1 Q9UBE0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19514725 0.82 TDP1 (0.56) ALDH1A1RAB9AMMP9MMP1MMP2
SCHEMBL292835 0.81 NPC1 (0.59) POLBALDH1A1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL11851173 0.80 NPC1 (0.57) POLBALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL29009279 0.79 ALDH1A1 (0.53) POLBALDH1A1NPC1RAB9ASMN1; SMN2
Hydrazine SCHEMBL8834679 0.78 NPC1 (0.56) POLBALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL22028110 0.77 LTA4H (0.58) POLBALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL292834 0.76 ALDH1A1 (0.60) POLBALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL3758807 0.76 ALDH1A1 (0.60) POLBALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL16689961 0.75 KMT2A (0.67) POLBALDH1A1NPC1RAB9ASMN1; SMN2
Acetic Acid SCHEMBL1868801 0.75 ALDH1A1 (0.63) POLBALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11324827-B2 Multifunctionalized polyethylene glycol derivative and preparation method therefor XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2022-05-10 US disclosed
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2017-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11324827-B2 Multifunctionalized polyethylene glycol derivative and preparation method therefor HDGF, F11, F12 POLB 1298/4885ALDH1A1 1582/4885NPC1 2429/4885
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR HDGF, F11, F12 POLB 1298/4885ALDH1A1 1582/4885NPC1 2429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.